aaavl2821 | Dark Hacker News

user:	aaavl2821
created:	November 21, 2017
karma:	3.0k
about:	biopharma and healthcare baybridgebio.com richard at baybridgebio.com

1.	Sophistical Refutations(en.wikipedia.org) 1 points by aaavl2821 227 days ago \| 0 comments
2.	Sophist(en.wikipedia.org) 15 points by aaavl2821 228 days ago \| 5 comments
3.	Can AI predict clinical trial outcomes?(baybridgebio.com) 2 points by aaavl2821 339 days ago \| 0 comments
4.	AI won't replace biotech analysts(baybridgebio.com) 1 points by aaavl2821 340 days ago \| 0 comments
5.	Show HN: Research Pharma Markets with AI(baybridgebio.com) 2 points by aaavl2821 1 year ago \| 0 comments
6.	Show HN: Search for drugs approved to treat a given disease(baybridgebio.com) 1 points by aaavl2821 1 year ago \| 0 comments
7.	Better obesity drugs are coming soon(baybridgebio.com) 2 points by aaavl2821 1 year ago \| 0 comments
8.	The Future of the Obesity Market(baybridgebio.com) 1 points by aaavl2821 1 year ago \| 0 comments
9.	The obesity drug landscape in one chart(baybridgebio.com) 3 points by aaavl2821 1 year ago \| 0 comments
10.	A primer on the obesity drug landscape(baybridgebio.com) 2 points by aaavl2821 1 year ago \| 0 comments
11.	AI-enabled biotech startup analysis(baybridgebio.com) 1 points by aaavl2821 2 years ago \| 0 comments
12.	Analyzing gene therapy startup in layman's terms(baybridgebio.com) 1 points by aaavl2821 2 years ago \| 0 comments
13.	AI Analysis of Biotech Startups(baybridgebio.com) 2 points by aaavl2821 2 years ago \| 0 comments
14.	AI investment analyst: initiating coverage on Neumora Therapeutics(baybridgebio.com) 1 points by aaavl2821 2 years ago \| 0 comments
15.	Quantifying risk / reward in biotech investing(baybridgebio.com) 1 points by aaavl2821 2 years ago \| 0 comments
16.	Valuing Biotech Licensing Deals(baybridgebio.com) 1 points by aaavl2821 2 years ago \| 0 comments
17.	Show HN: Value Biotech Licensing Deals(baybridgebio.com) 2 points by aaavl2821 2 years ago \| 0 comments
18.	Which VCs are still investing in biopharma?(baybridgebio.com) 1 points by aaavl2821 3 years ago \| 0 comments
19.	Biotech VC on pace for worst year since 2016(baybridgebio.com) 2 points by aaavl2821 3 years ago \| 0 comments
20.	The biotech venture capital crunch(baybridgebio.com) 1 points by aaavl2821 3 years ago \| 0 comments
21.	1 points by aaavl2821 3 years ago \| discuss
22.	Show HN: Interactive guide to valuing biotech companies(baybridgebio.com) 2 points by aaavl2821 3 years ago \| 0 comments
23.	Diagnosing the problem with biotech R&D(baybridgebio.com) 2 points by aaavl2821 3 years ago \| 0 comments
24.	Is Biotech Investing Sustainable?(baybridgebio.com) 1 points by aaavl2821 3 years ago \| 0 comments
25.	The next generation of biotech VCs(baybridgebio.com) 2 points by aaavl2821 3 years ago \| 0 comments
26.	Will a Recession Save Biotech?(baybridgebio.com) 2 points by aaavl2821 3 years ago \| 0 comments
27.	Biotech platforms are out, products are back in(baybridgebio.com) 16 points by aaavl2821 3 years ago \| 2 comments
28.	Bargain hunting for biotech stocks [video](youtube.com) 1 points by aaavl2821 3 years ago \| 0 comments
29.	Can big pharma buy every biotech startup?(baybridgebio.com) 1 points by aaavl2821 3 years ago \| 0 comments
30.	Biotech crossover investors facing steep losses(baybridgebio.com) 2 points by aaavl2821 3 years ago \| 0 comments